p95HER2-T cell bispecific antibody for breast cancer treatment Meeting Abstract


Authors: Vicario, R.; Ruiz, I. R.; Morancho, B.; Morales, C. B.; Herter, S.; Freimoser-Grundscholber, A.; Somandin, J.; Sam, J.; Ast, O.; Barriocanal, A. M.; Luque, A.; Escorihuela, M.; Varela, I.; Nuciforo, P.; Fasani, R.; Peg, V.; Rubio, I.; Cortes, J.; Serra, V.; Escriva, S.; Sperinde, J.; Chenna, A.; Huang, W.; Winslow, J.; Scaltriti, M.; Baselga, J.; Tabernero, J.; Umana, P.; Bacac, M.; Saura, C.; Klein, C.; Arribas, J.
Abstract Title: p95HER2-T cell bispecific antibody for breast cancer treatment
Meeting Title: 109th Annual Meeting of the American Association for Cancer Research (AACR)
Journal Title: Cancer Research
Volume: 78
Issue: 13 Suppl.
Meeting Dates: 2018 Apr 14-18
Meeting Location: Chicago, IL
ISSN: 0008-5472
Publisher: American Association for Cancer Research  
Date Published: 2018-07-01
Language: English
ACCESSION: WOS:000468818900435
DOI: 10.1158/1538-7445.Am2018-lb-292
PROVIDER: wos
Notes: Meeting Abstract: LB-292 -- Source: Wos
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Jose T Baselga
    484 Baselga
  2. Maurizio Scaltriti
    169 Scaltriti